Mesa Laboratories Inc (MLAB) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Mesa Laboratories Inc stock (MLAB) is currently trading at $83.60. Mesa Laboratories Inc PE ratio is 126.77. Mesa Laboratories Inc PS ratio (Price-to-Sales) is 1.84. Analyst consensus price target for MLAB is $104.50. WallStSmart rates MLAB as Sell.
- MLAB PE ratio analysis and historical PE chart
- MLAB PS ratio (Price-to-Sales) history and trend
- MLAB intrinsic value — DCF, Graham Number, EPV models
- MLAB stock price prediction 2025 2026 2027 2028 2029 2030
- MLAB fair value vs current price
- MLAB insider transactions and insider buying
- Is MLAB undervalued or overvalued?
- Mesa Laboratories Inc financial analysis — revenue, earnings, cash flow
- MLAB Piotroski F-Score and Altman Z-Score
- MLAB analyst price target and Smart Rating
Mesa Laboratories Inc
📊 No data available
Try selecting a different time range
MLAB Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Mesa Laboratories Inc (MLAB)
MLAB trades 1964% above its Graham fair value of $4.42, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Mesa Laboratories Inc (MLAB) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, institutional own.. Concerns around return on equity and revenue growth. Mixed signals suggest waiting for clearer direction before acting.
Mesa Laboratories Inc (MLAB) Key Strengths (2)
93.75% of shares held by major funds and institutions
Paying $1.84 for every $1 of annual revenue
Supporting Valuation Data
Mesa Laboratories Inc (MLAB) Areas to Watch (7)
Earnings declining -28.70%, profits shrinking
Very low returns on shareholder equity
Revenue growing slowly at 3.60% annually
Very thin margins, barely profitable
Thin operating margins with cost pressures present
Small-cap company with higher risk but more growth potential
Fairly priced relative to book value
Supporting Valuation Data
Mesa Laboratories Inc (MLAB) Detailed Analysis Report
Overall Assessment
This company scores 38/100 in our Smart Analysis, earning a F grade. Out of 9 metrics analyzed, 2 register as strengths (avg 9.0/10) while 7 fall into concern territory (avg 2.9/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Institutional Own., Price/Sales. Valuation metrics including Price/Sales (1.84) suggest the stock is attractively priced.
The Bear Case
The primary concerns are EPS Growth, Return on Equity, Revenue Growth. Some valuation metrics including Price/Book (2.37) suggest expensive pricing. Growth concerns include Revenue Growth at 3.60%, EPS Growth at -28.70%, which may limit upside. Profitability pressure is visible in Return on Equity at 2.18%, Operating Margin at 12.20%, Profit Margin at 1.51%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether EPS Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 2.18% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 3.60% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. EPS Growth and Return on Equity are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
MLAB Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
MLAB's Price-to-Sales ratio of 1.84x trades at a deep discount to its historical average of 7.25x (1th percentile). The current valuation is 86% below its historical high of 12.71x set in Nov 2018, and 6% above its historical low of 1.74x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~2.2x as trailing revenue scaled faster than the stock price.
Compare MLAB with Competitors
Top SCIENTIFIC & TECHNICAL INSTRUMENTS stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Mesa Laboratories Inc (MLAB) · TECHNOLOGY › SCIENTIFIC & TECHNICAL INSTRUMENTS
The Big Picture
Mesa Laboratories Inc is a strong growth company balancing expansion with improving profitability. Revenue reached 248M with 360% growth year-over-year. Profit margins are strong at 151.0%, reflecting pricing power and operational efficiency.
Key Findings
Revenue growing at 360% YoY, reaching 248M. This pace significantly outperforms most SCIENTIFIC & TECHNICAL INSTRUMENTS peers.
ROE of 218.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
What to Watch Next
Growth sustainability: can Mesa Laboratories Inc maintain 360%+ revenue growth, or will competition slow it down?
Valuation compression risk at a P/E of 126.8x. Any growth miss could trigger a sharp correction.
Sector dynamics: monitor SCIENTIFIC & TECHNICAL INSTRUMENTS industry trends, competitive moves, and regulatory changes that could impact Mesa Laboratories Inc.
Bottom Line
Mesa Laboratories Inc offers an attractive blend of growth (360% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(3 last 3 months)
Data sourced from SEC Form 4 filings
Last updated: 8:21:23 AM
About Mesa Laboratories Inc(MLAB)
NASDAQ
TECHNOLOGY
SCIENTIFIC & TECHNICAL INSTRUM...
USA
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company is headquartered in Lakewood, Colorado.